跳至主要内容
临床试验/CTRI/2025/08/092643
CTRI/2025/08/092643尚未招募2 期

Effectiveness of Homoeopathic Medicines in LM Potency for Managing Perennial Allergic Rhinitis: A Prospective Study Using RCAT Score

Post graduate research funded by college. To1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2025年8月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
34
试验地点
1
主要终点
Change in RCAT (Rhinitis Control Assessment Test) score.

研究概览

简要总结

This is a prospective, single-arm, observational study conducted at Sarada Krishna Homoeopathic Medical College and Hospital (SKHMC), Kulasekharam, to evaluate the effectiveness of individualized homoeopathic medicines in LM potency for managing perennial allergic rhinitis using the Rhinitis Control Assessment Test (RCAT) score. Thirty-four pre-diagnosed cases fulfilling the inclusion criteria will be selected purposively from the OPD, IPD, and rural health training centres. Follow-up will be done weekly or biweekly for one year. Outcomes include change in symptom control and reduction in the need for conventional anti-allergic medications.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
6.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Acute upper respiratory tract infections.
  • Presence of bronchial asthma or other chronic respiratory illness.
  • Use of anti-allergic or steroidal medications during the study period.
  • Known hypersensitivity to any of the ingredients in the medicine used.
  • Pregnant or lactating women.
  • Patients with serious systemic illness.

排除标准

  • Patients suffering from acute upper respiratory tract infections.
  • Patients having bronchial asthma and other chronic respiratory conditions.
  • Patients under anti-allergic treatment.
  • Pregnant and lactating women.
  • Patients with serious systemic illness.

结局指标

主要结局

Change in RCAT (Rhinitis Control Assessment Test) score.

时间窗: Baseline, at 2-week intervals during treatment.

次要结局

  • Reduction in use of conventional anti-allergic medications. The medicine will be administered orally, one dose, once in 2 weeks for a period of 3 months
  • Reduction in use of conventional anti-allergic medications.(Throughout the treatment period.)

研究者

发起方
Post graduate research funded by college. To
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Roy Thomas

Sarada Krishna Homoeopathic Medical College & Hospital

研究点 (1)

Loading locations...

相似试验